-
Pharma Pollution: Shut The Back Door On Superbugs
EPHA and Changing Markets unveils how the pharmaceutical industry’s role in contributing to the spread of antimicrobial resistance (AMR) via pollution of the environment in a new briefing. The failure to produce drugs responsibly and ensure transparency and respect for environmental standards in global supply chains is contributing to the proliferation of drug-resistant infections.
- Categories
- Environment, Health Care
-
OraSure gets Zika funding
OraSure Technologies will get federal funding to develop a Zika test despite Congress' failure to allocate money to fight the mosquito-borne disease. The south Bethlehem diagnostics company announced Tuesday it had been awarded a contract for up to $16.6 million from the U.S. Department of Health and Human Services.
- Categories
- Health Care
-
Cost Of Healthy Living: Coca-Cola May Shut Down South African Plant Over Sugar Tax
Coca-Cola Beverages Africa, the continent’s largest soft drinks bottler, may close business in South Africa if the government goes ahead with a proposed tax of 20 percent on sugary drinks from April 1, 2017 in a bid to curb obesity and unhealthy diets.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- public health
-
Paper-based Test Identifies Bogus and Poor Quality Drugs
Counterfeit and substandard medications are a serious problem in the developing world, potentially harming patients who desperately need medical treatment. Some of these drugs — including the antibiotics ciprofloxacin and ceftriaxone — have been deemed essential by the World Health Organization for the treatment of infections.
- Categories
- Health Care
-
Liberian Nurses Learn to Spot Danger Signs in Babies as Healthcare Gets Shot in Arm
The Well Baby clinic in Buchanan is busy. But that’s not unusual. The clinic, a two-hour drive from Liberia’s capital, Monrovia, sees between 700 and 1,000 mothers and children each week.
- Categories
- Education, Health Care
- Region
- Sub-Saharan Africa
- Tags
- public health
-
As globe-threatening yellow fever epidemic explodes in Congo, people ask ‘where is the vaccine?’
Here in Kinshasa, they’re using bug spray to repel a pandemic. At first glance, it looks like a bloody ambush on civilians: Dozens in uniform are storming into a bustling marketplace bearing on their shoulders what look like bazookas.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Africa’s Health Strategy Can Benefit India’s Pharma Firms
With a $106.8 million strategy to tackle Africa's public health emergencies over the next five years, stakeholders here feel it will be an ideal opportunity for the Indian pharma companies to take advantage, with Cipla taking the lead.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- public health, research
-
The Price of Zika? About $4 Million Per Child
TO TALK ABOUT Zika virus control is to talk about money. Vaccine development, mosquito abatement, and even the distribution of DEET repellant takes (and currently lacks) major federal dollars. When, last week, the US Department of Health and Human Services declared Zika a public health emergency in Puerto Rico, it was in part a means to a better-funded end.
- Categories
- Health Care
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.